Early Use of Gocovri Could Delay Levodopa-induced Dyskinesia: Study

Early Use of Gocovri Could Delay Levodopa-induced Dyskinesia: Study

315274

Early Use of Gocovri Could Delay Levodopa-induced Dyskinesia: Study

Early treatment with Gocovri (amantadine) may delay the onset of dyskinesia, the uncontrolled movements that are a common side effect of levodopa use, according to a new study. The study, “Amantadine Treatment and Delayed Onset of Levodopa-Induced Dyskinesia in Patients with Early Parkinson’s Disease” was published in the European Journal of Neurology. Levodopa and its derivatives are a mainstay of treatment for Parkinson’s disease. Although these medications are effective for controlling disease symptoms, they also cause…

You must be logged in to read/download the full post.